Search Results - "Kanas, Gena"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors by Kanas, Gena P, Taylor, Aliki, Primrose, John N, Langeberg, Wendy J, Kelsh, Michael A, Mowat, Fionna S, Alexander, Dominik D, Choti, Michael A, Poston, Graeme

    Published in Clinical epidemiology (2012)
    “…Hepatic metastases develop in approximately 50% of colorectal cancer (CRC) cases. We performed a review and meta-analysis to evaluate survival after resection…”
    Get full text
    Journal Article
  2. 2

    Treatment patterns in non-small-cell lung cancer in China: Results from the CancerMPact survey 2020 by Durbin, Laura, Murali, Bhavna, Li, Song, Zhao, Linda, Hawthorne, Stephanie, Kanas, Gena, Davis, Christine, Clark, Otávio

    “…•Chinese physicians favor adjuvant therapy over neoadjuvant/peri‑operative in NSCLC.•At least one biomarker test is performed in 75% of the…”
    Get full text
    Journal Article
  3. 3

    Use of electronic medical records in oncology outcomes research by Kanas, Gena, Morimoto, Libby, Mowat, Fionna, O'Malley, Cynthia, Fryzek, Jon, Nordyke, Robert

    Published in ClinicoEconomics and outcomes research (01-01-2010)
    “…Oncology outcomes research could benefit from the use of an oncology-specific electronic medical record (EMR) network. The benefits and challenges of using EMR…”
    Get full text
    Journal Article
  4. 4

    Epidemiology of diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL) in the United States and Western Europe: population-level projections for 2020-2025 by Kanas, Gena, Ge, Wenzhen, Quek, Ruben G. W., Keeven, Katie, Nersesyan, Knar

    Published in Leukemia & lymphoma (02-01-2022)
    “…Diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL) treatments have been rapidly evolving for patients treated in later lines of therapy (LoT)…”
    Get full text
    Journal Article
  5. 5

    Population-Level Projections for Multiple Myeloma Patients By Line of Therapy in the USA by Kanas, Gena, Clark, Otavio, Keeven, Katie, Nersesyan, Knar, Sansbury, Leah, Hoggea, Cosmina

    Published in Blood (05-11-2020)
    “…Introduction: Treatment for multiple myeloma (MM) has evolved over time, leading to improved survival outcomes for patients. However, information on real world…”
    Get full text
    Journal Article
  6. 6

    Treatment of HR+/HER2− breast cancer in urban mainland China: results from the CancerMPact Survey 2019 by Murali, Bhavna, Durbin, Laura, Vijaykumar, Sapna, Yang, Linda, Li, Song, Zhao, Linda, Hawthorne, Stephanie, Kanas, Gena, Davis, Christine, Clark, Otávio

    Published in Breast cancer research and treatment (01-10-2022)
    “…Purpose To report the treatment utilization patterns for hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2−) breast…”
    Get full text
    Journal Article
  7. 7

    Estimate of multiple myeloma patients by line of therapy in the USA: population-level projections 2020–2025 by Kanas, Gena, Clark, Otavio, Keeven, Katie, Nersesyan, Knar, Sansbury, Leah, Hogea, Cosmina

    Published in Future oncology (London, England) (01-03-2021)
    “…To report the results of a patient epidemiology model for multiple myeloma (MM) treatment by line of therapy (LOT) in the USA. Surveillance, Epidemiology and…”
    Get full text
    Journal Article
  8. 8

    Treatment patterns in non-small-cell lung cancer in USA: results of the CancerMPact Survey 2018 by Robinson, David, Hawthorne, Stephanie, Zhao, Linda, Hanson, Madelyn, Kanas, Gena, Davis, Christine, Clark, Otavio

    Published in Future oncology (London, England) (01-03-2020)
    “…To report the results of a survey of USA physicians (CancerMPact) that treat non-small-cell lung cancer patients. 60 physicians were surveyed. Questions…”
    Get full text
    Journal Article
  9. 9

    Metastatic non-small-cell lung cancer without driver mutations: projections by therapy line in Western Europe, 2021–2026 by Zhu, Xinmei, Durbin, Laura, Kanas, Gena, Phiri, Kelesitse, Keeven, Katie, Clark, Otavio, Nersesyan, Knar, Aziez, Amine, Stojadinovic, Alexander, Bell, Kelly F

    Published in Future oncology (London, England) (01-10-2023)
    “…To estimate the incidence, prevalence and treated prevalence by line of therapy (LOT) for non-small-cell lung cancer (NSCLC) patients without driver mutations…”
    Get full text
    Journal Article
  10. 10

    Physician reported treatment patterns and outcomes in metastatic bladder cancer in the USA: the CancerMPact ® Survey 2020 by Bueno, Ana Paula A, Clark, Otavio, Turnure, Matthew, Moreira, Eloisa S, Chang, Jane, Hou, Ningqi, Li, Si, Kim, Ruth, Kearney, Mairead, Kirker, Melissa, Kanas, Gena

    Published in Future oncology (London, England) (01-03-2024)
    “…This study assessed physician-reported treatment patterns for metastatic bladder cancer. A total of 106 USA-based physicians were surveyed in 2020 using the…”
    Get more information
    Journal Article
  11. 11

    Treatment patterns in metastatic bladder cancer in Japan: results of the CancerMPact ® survey 2020 by A Bueno, Ana Paula, Clark, Otavio, Turnure, Matthew, Moreira, Eloisa S, Yuasa, Akira, Sugiyama, Shigeru, Kirker, Melissa, Li, Si, Hou, Ningqi, Chang, Jane, Kearney, Mairead, Kanas, Gena

    Published in Future oncology (London, England) (01-03-2024)
    “…To assess physician-reported treatment of metastatic bladder cancer in Japan. 76 physicians completed the CancerMPact survey in July 2020, considering patients…”
    Get more information
    Journal Article
  12. 12

    Epidemiology of paediatric immune thrombocytopenia in the General Practice Research Database by Yong, Mellissa, Schoonen, Wilma Marieke, Li, Lin, Kanas, Gena, Coalson, Jenna, Mowat, Fionna, Fryzek, Jon, Kaye, James A.

    Published in British journal of haematology (01-06-2010)
    “…Summary This study assessed the incidence of immune thrombocytopenia (ITP) and characteristics associated with ITP in the paediatric population using the…”
    Get full text
    Journal Article
  13. 13

    Patterns of Care and Outcomes for NonMetastatic Prostate Cancer in the United States: Results of the CancerMPact [R] Survey 2018 by Moreira, Eloisa de Sa, Robinson, David, Hawthorne, Stephanie, Zhao, Linda, Hanson, Madelyn, Kanas, Gena, Turnure, Matthew, Davis, Christine, Clark, Otavio

    Published in Cancer management and research (31-12-2021)
    “…Purpose: We describe patterns of care and treatment outcomes for non-metastatic PCa (nmPCA), either hormone-sensitive or castration-resistant, in the United…”
    Get full text
    Journal Article
  14. 14

    Treatment of Advanced/Metastatic Melanoma in the United States and Western Europe: Results of the CancerMPact Survey by Hawthorne, Stephanie, Zhao, Linda, Hanson, Madelyn, Kanas, Gena, Davis, Christine, Robinson, David, Turnure, Matthew, Clark, Otavio

    Published in Cancer management and research (01-01-2020)
    “…Melanoma treatment has substantially changed over the last several years, yet little information regarding physician's preferences around treatment exists. Our…”
    Get full text
    Journal Article
  15. 15

    Patterns of Care and Outcomes for Non-Metastatic Prostate Cancer in the United States: Results of the CancerMPact ® Survey 2018 by de Sá Moreira, Eloisa, Robinson, David, Hawthorne, Stephanie, Zhao, Linda, Hanson, Madelyn, Kanas, Gena, Turnure, Matthew, Davis, Christine, Clark, Otavio

    Published in Cancer management and research (01-01-2021)
    “…We describe patterns of care and treatment outcomes for non-metastatic PCa (nmPCA), either hormone-sensitive or castration-resistant, in the United States of…”
    Get full text
    Journal Article